Ocular Imaging Study Using Advanced OCT

University of California, Los Angeles1,000 enrolled

Overview

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Retinal Vascular Disorder Macular Degeneration

Eligibility

Sex: ALLMin age: 18 YearsMax age: 115 Years

Medical Language ↔ Plain English

Inclusion Criteria: • Any patient with abnormal retinal findings as determined by investigators. Exclusion Criteria: * Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging. * Participants who are unable to maintain retinal fixation on a specified target. * Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place. * Patients with media opacity which preclude high quality imaging.

Ocular Imaging Study Using Advanced OCT

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes